D'Elia Maria, Marino Carmen, Celano Rita, Napolitano Enza, Colarusso Chiara, Sorrentino Rosalinda, D'Ursi Anna Maria, Rastrelli Luca
Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.
National Biodiversity Future Center-NBFC, 90133 Palermo, Italy.
Antioxidants (Basel). 2025 Jun 18;14(6):753. doi: 10.3390/antiox14060753.
The aim of this study was to evaluate the impact of a novel antioxidant formulation (RE:PAIR, RP-25) containing CoQ10, alpha-lipoic acid, and Chaga extract on mitochondrial dysfunction and oxidative stress. To explore the activity of the formulation on neuronal cells, we explored cell metabolism and its activity as an antioxidant, using a combination of NMR-based metabolomics and UHPLC-HRMS analytical techniques.
SH-SY5Y neuroblastoma cells were treated with RP-25, and cell viability was assessed via CCK-8 assay. Metabolomic profiles of the treated and untreated cells were analyzed by 1D-NMR, providing insights into both intracellular metabolites (endometabolome) and excreted metabolites (exometabolome). Additionally, a UHPLC-HRMS method was developed for quality control and analysis of the RP-25 formulation. Multivariate statistical approaches, including PLS-DA and volcano plot analyses, were used to identify key metabolic changes. Changes in mitochondrial membrane potential were assessed by means of TMRE assay, while radical oxygen species (ROS) were measured by means of the DCHF assay.
RP-25 treatment did not affect cell viability but significantly increased metabolic pathways, including amino acid biosynthesis, oxidative phosphorylation, and glycolysis. Higher levels of ATP, glutamate, tyrosine, and proline were observed in treated cells than in control cells, indicating enhanced cellular energy production, as also proved by the increased stability of the mitochondrial membrane after RP-25 treatment, an index of preserved mitochondrial functions. In support, the formulation RP-25 showed antioxidant activity when cells underwent peroxide oxygen stimulation. This effect was mainly due to the combination of Chaga, CoQ10, and ALA, main components of the RP25 formulation. Moreover, the analysis of enriched pathways highlighted that RP formulation influenced mitochondrial energy and oxidative stress response.
RP-25 demonstrated biological activity in that it mitigated mitochondrial dysfunction and oxidative stress in neuronal cells, with potential implications in neuronal diseases associated with dysfunctional mitochondria.
本研究旨在评估一种含有辅酶Q10、α-硫辛酸和桦褐孔菌提取物的新型抗氧化剂配方(RE:PAIR,RP - 25)对线粒体功能障碍和氧化应激的影响。为了探究该配方在神经元细胞上的活性,我们结合基于核磁共振的代谢组学和超高效液相色谱 - 高分辨质谱分析技术,研究了细胞代谢及其作为抗氧化剂的活性。
用RP - 25处理SH - SY5Y神经母细胞瘤细胞,并通过CCK - 8法评估细胞活力。通过一维核磁共振分析处理组和未处理组细胞的代谢组学图谱,以深入了解细胞内代谢物(内膜代谢组)和排泄代谢物(外膜代谢组)。此外,还开发了一种超高效液相色谱 - 高分辨质谱方法用于RP - 25配方的质量控制和分析。采用包括偏最小二乘判别分析和火山图分析在内的多变量统计方法来识别关键的代谢变化。通过TMRE法评估线粒体膜电位的变化,而通过DCHF法测量活性氧(ROS)。
RP - 25处理不影响细胞活力,但显著增加了包括氨基酸生物合成、氧化磷酸化和糖酵解在内 的代谢途径。与对照细胞相比,处理组细胞中ATP、谷氨酸、酪氨酸和脯氨酸水平更高,这表明细胞能量产生增强,RP - 25处理后线粒体膜稳定性增加也证明了这一点,线粒体膜稳定性是线粒体功能保存的一个指标。此外,当细胞受到过氧化物氧刺激时,配方RP - 25表现出抗氧化活性。这种作用主要归因于RP25配方的主要成分桦褐孔菌、辅酶Q10和α-硫辛酸的组合。此外,对富集途径的分析突出表明,RP配方影响线粒体能量和氧化应激反应。
RP - 25具有生物学活性,因为它减轻了神经元细胞中的线粒体功能障碍和氧化应激,对与线粒体功能障碍相关的神经元疾病具有潜在影响。